Amos Toren

Prof. Amos Toren is a pediatric hemato-oncologist and BMT specialist at Sheba Medical Center. He served as Director of the pediatric oncology and bone marrow transplant division. Dr. Toren holds board certifications in pediatrics, pediatric hemato-oncology, and bone marrow transplantation along with a PhD in Human Genetics.

Specialization and Advanced Therapies

Dr. Toren treats children and young adults up to age 30. He focuses on leukemia, lymphoma, and rare pediatric cancers. He uses CAR T-cell therapy for relapsed and treatment-resistant cases. This advanced immunotherapy uses modified immune cells to fight cancer.

Dr. Toren also treats chronic blood disorders and primary immune deficiencies. He performs complex bone marrow and stem cell transplantations. The doctor integrates genomic data to create individualized treatment strategies. His approach involves cytokine-induced killer cells and targeted therapies.

These methods help improve outcomes for high-risk pediatric malignancies. Dr. Toren specializes in treating rare and complex pediatric cancers. He offers cellular immunotherapy approaches to patients who do not respond to standard treatments. He also provides care for pediatric oncology and hematologic malignancies.

Professional Roles and Leadership

Dr. Toren held the position of Director of Pediatric Hemato-Oncology at Sheba Medical Center. He served two terms as Head of the Hematology Division at Tel Aviv University. The specialist contributes to national policy as a member of the Ministry of Health Cord Blood Committee. He also speaks Hebrew and English.

Research and Academic Contributions

Dr. Toren conducts translational research on pediatric brain tumors and cellular immunotherapy. He collaborates with global institutions such as St. Jude, the NIH, and St. Anna Children’s Hospital in Austria. His academic work is published in peer-reviewed journals. Key research titles include:

• "Immunoglobulin prophylaxis in pediatric stem cell transplantation"
• "Overcoming resistance to PARP inhibitors in cancer therapy"

Education and Training

• Medical Degree – Faculty of Medicine, Tel Aviv University, Israel
• Residency in Pediatrics – Sheba Medical Center, Israel
• Residency in Hematology – Sheba Medical Center, Israel
• Specialization in Pediatric Hemato-Oncology and Bone Marrow Transplantation – Hadassah Medical Center, Israel
• PhD in Human Genetics – Tel Aviv University, Israel
• Master of Health Administration – Recanati Business School, Tel Aviv University

Professional Memberships

• American Society of Hematology (ASH)
• Children’s Oncology Group (COG)
• European Society of Pediatric Hematology (ESPHI)
• European Group for Blood and Marrow Transplantation (EBMT)
• Center for International Blood and Marrow Transplant Research (CIBMTR)